Xcout Intel
Decibel Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Decibel Therapeutics, Inc. among biotechnology companies — ranked by similarity to what Decibel Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see Decibel Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Decibel Therapeutics, Inc.
Decibel Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, which agreed to merge with Regeneron Pharmaceuticals.
Decibel Therapeutics, Inc. at a glance
Decibel Therapeutics, Inc. is a biotechnology company headquartered in United States. It has raised at least $87.1M across the 2 funding rounds on record. Its most recent funding round raised $54.8M in November 2020. Xcout tracks 18 named people at Decibel Therapeutics, Inc., including Leonard S. Schleifer (Board co-Chair, President and Chief Executive Officer).
Decibel Therapeutics, Inc. leadership
- Leonard S. SchleiferBoard co-Chair, President and Chief Executive Officer
- George D. YancopoulosBoard co-Chair, President and Chief Scientific Officer
- Chris FenimoreExecutive Vice President, Finance and Chief Financial Officer
- Rick HallSenior Vice President, Human Resources and Chief Human Resources Officer
- Brook JenningsSenior Vice President, Global Immunology Commercial Business Unit
- Christina ChanSenior Vice President, Corporate Affairs
12 more named people on record for Decibel Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Decibel Therapeutics, Inc. funding rounds
At least $87.1M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $54.8M | — | |
| SEC Form D filing | $32.3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Decibel Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to Decibel Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Regeneron is a biopharmaceutical company that researches, develops, and commercializes medicines for people with serious diseases. Utilizing proprietary technologies in antibodies and genetic medicines, the company serves patients globally by addressing conditions in areas such as oncology, immunology, ophthalmology, and rare diseases.
Similar biotechnology company
Rgenta Therapeutics, Inc. is a biotechnology research company headquartered in Woburn, Massachusetts, that focuses on unlocking the therapeutic potential of disease-relevant RNA targets.
Similar biotechnology company
Exsilio Therapeutics Inc. is a biotechnology company headquartered in Boston, Massachusetts, founded in 2022 to pioneer genomic medicines and advanced genetic therapies.
Biotech
Intellia Therapeutics, Inc. is a biotechnology firm dedicated to advancing therapeutic treatments through its expertise in genome editing. The company's pipeline includes several in vivo (administered within the body) programs. NTLA-2001 is currently undergoing a Phase 1 clinical trial for transthyretin amyloidosis, while NTLA-2002 targets hereditary angioedema. Additionally, Intellia is developing various other liver-focused therapies for conditions such as hemophilia A and B, hyperoxaluria Type 1, and alpha-1 antitrypsin deficiency. Its ex vivo (processed outside the body) pipeline features NTLA-5001, a candidate for acute myeloid leukemia. The company is also progressing proprietary programs focused on creating engineered cell therapies to address diverse oncological and autoimmune disorders. At the core of Intellia's technology is the Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. Intellia Therapeutics, Inc. has established multiple licensing and collaboration agreements. These include a partnership with Novartis Institutes for BioMedical Research, Inc. to engineer hematopoietic stem cells for treating sickle cell disease, and a co-development agreement with Regeneron Pharmaceuticals, Inc. for potential products against hemophilia A and B. The company also collaborates with Ospedale San Raffaele and holds a strategic alliance with SparingVision SAS to develop novel genomic medicines for ocular diseases, leveraging CRISPR/Cas9 technology. The company, initially known as AZRN, Inc., was founded in 2014 and operates from its headquarters in Cambridge, Massachusetts.
Similar biotechnology company
Dewpoint Therapeutics is an integrated drug discovery platform company headquartered in Boston, Massachusetts. The firm leverages advanced biotechnology to translate condensate biology into novel medicines for various therapeutic areas.
Similar biotechnology company
Delix Therapeutics is a privately held biopharmaceutical company headquartered in Boston, Massachusetts, focused on transforming the treatment of brain health through neuroscience.
Similar biotechnology company
Beacon Therapeutics is a clinical-stage biotechnology company dedicated to saving and restoring sight for people living with rare and prevalent ocular diseases. The company works to deliver advanced retinal gene therapies to patients experiencing blindness.
Life Science
Selecta Biosciences, Inc. is a clinical-stage biotechnology company located in Watertown, Massachusetts, focused on unlocking the full potential of biologic therapies. The company engages in advanced biotechnology research and corporate mergers.
Similar biotechnology company
Memento Medicines, Inc. is a privately held biotechnology company headquartered in Boston, Massachusetts, focused on developing novel biologic therapies for retinal diseases.
Similar biotechnology company
Aileron Therapeutics, Inc. is a clinical-stage biopharmaceutical company with principal executive offices located in Cambridge, Massachusetts. The company went public through a reverse merger and is involved in therapeutic acquisitions and development.
Similar biotechnology company
Regenacy Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in Waltham, Massachusetts. The company focuses on developing breakthrough treatments for diabetic neuropathies and other debilitating conditions.
Similar biotechnology company
Verve Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, dedicated to pioneering single-course gene editing medicines for cardiovascular disease.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Decibel Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Decibel Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →